The impact of SNPs and other molecular diagnostic markers is now being felt--this will grow as
more molecular markers are validated and launched for their diagnostic and prognostic value.
This report analyzes the technologies and their impact in the molecular diagnostics marketplace.
We present an assessment of all the technologies of value in this space and which market segments
are impacted and affected by these technologies.
Furthermore, in this report are presented qualitative and quantitative market analysis of the
molecular diagnostics space. We present total industry revenues, growth rates, and the various
qualitative drivers that are contributing to the growth of the marketplace.
Table of Contents
Executive Summary
Molecular Diagnostics: Overview of the space
Value drivers of molecular diagnostics
Growth drivers of molecular diagnostics
Quantitative Market Summary-I
Quantitative Market Summary-II
Quantitative Market Summary-III
Types of molecular diagnostic tests
Emerging themes in molecular diagnostics
Technologies, Trends, & Market Segments in the Molecular Diagnostics Space
Molecular diagnostics testing
Molecular diagnostics (Vocabulary and acronyms)
Molecular targets
Testing formats
Testing arenas
Infectious disease
Human genetic targets
Genetics
Test development
Samples
Sample preparation
PCR
Real-time PCR
SYBR Green
MultiCode RTx
Taq-Man
HybProbe
Molecular Beacons
bDNA
TMA
Invader
ELISA Formats
Solid Support Systems
2-D arrays
2-D chips
MultiCode PLx
Tag-It
Signature
Comparisons
Sequencing
Automation
Real-time PCR automation
TMA automation
MultiCode Automation
Production and Regulatory Acronyms
Production
Approval Processes in the Molecular Diagnostics Space
Test development standards
FDA approved tests
Approval process US
Approval process-European Union
Approval process Japan
Molecular diagnostics market analysis
Where are we today
Evolution of molecular diagnostics
Types of tests/products
R&D journey of a genomics test
Molecular diagnostics tests revenues
Adoption rates of molecular diagnostics tests
Quantitative market summary-I
Quantitative market summary-II
Quantitative market summary-III
Quantitative market summary-IV
Evolution of molecular diagnostic technologies
Molecular diagnostics: Where is the market heading?
Molecular diagnostics in relation to other genomics-based approaches
Biological targets for development of molecular diagnostics
Development of molecular diagnostic tests
Company Profiles
Abbott Diagnostics
Bayer Diagnostics
Biosite Diagnostics
Celera Diagnostics
Cepheid
DiaDexus
DiagnoSwiss SA
Digene Corporation
Genaissance Pharmaceuticals, Inc.
Gen-Probe, Inc.
Innogenetics NV
Myriad Genetics
Quest Diagnostics
Roche Diagnostics
Veridex, LLC
Other market participants with product offerings-interest in the molecular diagnostics space
